IGF1R and glioblastoma: A more recent study demonstrated that combination of the IGFR inhibitor NVP-AEW541 with dasatinib led to increased apoptosis in GBM cell lines, but not in nonneoplastic human astrocytes, and synergistically inhibited clonogenic survival [50].